BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6723223)

  • 1. Evaluation of the Chiou method for determining theophylline dosages.
    Johnson MH; Burkle WS
    Clin Pharm; 1984; 3(2):174-8. PubMed ID: 6723223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability of theophylline clearance in determining chronic oral dosage regimens.
    Slotfeldt ML; Johnson CE; Grambau G; Weg JG
    Am J Hosp Pharm; 1979 Jan; 36(1):66-8. PubMed ID: 758787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid estimation of total body clearance of theophylline in patients receiving intravenous aminophylline infusion.
    Lau AH; O'Connor T; Lam G; Lui CY; Al-Bazzaz FJ; Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):12-5. PubMed ID: 3957483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theophylline: constant-rate infusion predictions.
    Mesquita CA; Sahebjami H; Imhoff T; Thomas JP; Myre SA
    Ther Drug Monit; 1984; 6(2):157-63. PubMed ID: 6740734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of 11 methods for predicting theophylline dose.
    Rodvold KA; Paloucek FP; Zell M
    Clin Pharm; 1986 May; 5(5):403-8. PubMed ID: 3720210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion from intravenous aminophylline to sustained-release theophylline: computer simulation versus in vivo results.
    Hatton RC; Gotz VP; Robinson JD; Russell WL; Ryerson GG
    Clin Pharm; 1983; 2(4):347-52. PubMed ID: 6883961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early estimate of theophylline clearance during intravenous infusion.
    Rizzo A; Mirabella A; Ferrara G; Mangiacavallo A; Bonanno A; Bonsignore G
    Eur J Respir Dis; 1986 Apr; 68(4):291-7. PubMed ID: 3732424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonlinear regression program to individualize oral theophylline dosage.
    Bauer LA; Black DJ; Koup JR
    Clin Pharm; 1984; 3(3):288-90. PubMed ID: 6547379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. System for clinical pharmacokinetic monitoring of theophylline therapy.
    Koup JR; Schentag JJ; Vance JW; Kuritzky PM; Pyszczynski DR; Jusko WJ
    Am J Hosp Pharm; 1976 Sep; 33(9):949-56. PubMed ID: 790952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of theophylline clearance using condition correction factors.
    Haumschild MJ; Murphy JE
    Clin Pharm; 1985; 4(1):59-64. PubMed ID: 3971684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adaptation of the oral dosage of theophylline to the asthmatic child. Value of a kinetic test by the intravenous route].
    Albertini M; Lapalus P; Maurin S; Boutte P; Mariani R
    Arch Fr Pediatr; 1982 Nov; 39(9):671-5. PubMed ID: 7165461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice.
    Arbab OA; Wiggins J; Ayres JG; Stableforth DE
    Br J Dis Chest; 1985 Apr; 79(2):161-71. PubMed ID: 3986120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intravenous theophylline: adaptation of dosage to blood theophylline levels at admission and to clearance].
    Laaban JP; Dupeyron JP; Guyon F; Drieu L; Rochemaure J; Fabiani P
    Ann Med Interne (Paris); 1986; 137(5):415-9. PubMed ID: 3813276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of intravenous theophylline in pregnant patients at term.
    Romero R; Kadar N; Gonzales Govea F; Hobbins JC
    Am J Perinatol; 1983 Oct; 1(1):31-5. PubMed ID: 6680648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a pharmacokinetic method for establishing doses of aminophylline to treat acute bronchospasm.
    Pancorbo S; Davies S; Raymond JL
    Am J Hosp Pharm; 1981 Jun; 38(6):851-6. PubMed ID: 7246557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of theophylline in acute asthma.
    Simons FE; Simons KJ; Shapiro GG; Pierson WE; Bierman CW
    J Med; 1978; 9(1):81-90. PubMed ID: 276563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of theophylline clearance during intravenous aminophylline infusions.
    Gilman TM; Muir KT; Jung RC; Walberg CB
    J Pharm Sci; 1985 May; 74(5):508-14. PubMed ID: 4020626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability and predictive value of salivary theophylline levels.
    Jaber M; Schneider AT; Goldstein S; Sergiou H; Bjornson L; Chiaramonte LT
    Ann Allergy; 1987 Feb; 58(2):105-8. PubMed ID: 3813126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of five methods for predicting phenobarbital concentrations in pediatric patients.
    Beck DE; Ravis WR; Snead OC
    Clin Pharm; 1986 Sep; 5(9):754-9. PubMed ID: 3757446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.